Suchergebnisse - "Yao, Qigu"

PubPharm (30)

1

Corrigendum to "A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation" [Pharmacol. Res. 194 (2023) 106851

enthalten in: Pharmacological research | 2024

von Gao, F. | Yao, Q. | Zhu, J. | +10

ErratumFor: Pharmacol Res. 2023 Aug;194:106851. - PMID 37453673

2

MSC-derived exosomes attenuate hepatic fibrosis in primary sclerosing cholangitis through inhibition of Th17 differentiation

enthalten in: Asian journal of pharmaceutical sciences | 2024

von Chen, W. | Lin, F. | Feng, X. | +10

3

Co-delivery of azithromycin and ibuprofen by ROS-responsive polymer nanoparticles synergistically attenuates the acute lung injury

enthalten in: Biomaterials advances | 2023

von Muhammad, W. | Zhang, Y. | Zhu, J. | +11

4

A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation

enthalten in: Pharmacological research | 2023

von Gao, F. | Yao, Q. | Zhu, J. | +10

ErratumIn: Pharmacol Res. 2024 Mar 8;:107135. - PMID 38461139

5

Triple-Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo-Immunotherapy in Preclinical Cancer Models

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2023

von Shi, X. | Shu, L. | Wang, M. | +8

6

Characteristic Analysis of Featured Genes Associated with Cholangiocarcinoma Progression

enthalten in: Biomedicines | 2023

von Yao, Q. | Chen, W. | Gao, F. | +8

7

Pooled Analysis of Mesenchymal Stromal Cell-Derived Extracellular Vesicle Therapy for Liver Disease in Preclinical Models

enthalten in: Journal of personalized medicine | 2023

von Fang, X. | Gao, F. | Yao, Q. | +4

8

Efficacy and Safety of PD-1/PD-L1 Checkpoint Inhibitors versus Anti-PD-1/PD-L1 Combined with Other Therapies for Tumors : A Systematic Review

enthalten in: Cancers | 2023

von Zhang, Y. | Yao, Q. | Pan, Y. | +7

9

Human Placental Mesenchymal Stem Cells Relieve Primary Sclerosing Cholangitis via Upregulation of TGR5 in Mdr2-/- Mice and Human Intrahepatic Cholangiocyte Organoid Models

enthalten in: Research (Washington, D.C.) | 2023

von Yao, Q. | Chen, W. | Yu, Y. | +9

10

Triple‐Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo‐Immunotherapy in Preclinical Cancer Models

enthalten in: Advanced Science | 2023

von Shi, X. | Shu, L. | Wang, M. | +8